A federal appeals court in Chicago will hear oral arguments in drug manufacturer Eli Lilly’s 340B contract pharmacy lawsuit against the federal government on Oct. 31, the court announced on Tuesday.
The half-hour session will take place one week after a federal appeals court in Washington, D.C., hears arguments in Novartis and United Therapeutics’ consolidated lawsuits bringing similar claims against the U.S. Health and Human Services Department (HHS) and Health Resources and Services Administration (HRSA).
A federal appeals court in Chicago will hear oral arguments in drug manufacturer Eli Lilly’s 340B contract pharmacy lawsuit against the federal government on Oct. 31, the court announced on Tuesday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
